PHARMACOKINETIC AND PHARMACODYNAMIC TOLERANCE OF A NEW ANTICONVULSANT AGENT (3-SULFAMOYLMETHYL-1,2-BENZISOXAZOLE) COMPARED TO PHENOBARBITAL, DIPHENYLHYDANTOIN AND CARBAMAZEPINE IN RATS